Literature DB >> 8787875

Influence of pH on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides and their postantibiotic effects.

Y Q Xiong1, J Caillon, H Drugeon, G Potel, D Baron.   

Abstract

Adaptive resistance to aminoglycosides in Pseudomonas aeruginosa and other gram-negative bacilli is usually induced by the initial exposure to the drug. We investigated the influence of pH on the adaptive resistance of a clinical P. aeruginosa strain to aminoglycosides in vitro and on their postantibiotic effects. For adaptive resistance, the first-exposure concentrations of both amikacin and netilmicin were one, two, four, and eight times the MIC of each drug and the second-exposure concentrations were two times the MIC of each drug. Adaptive resistance was greater and more prolonged with higher initial aminoglycoside concentrations, and the bactericidal effects of the aminoglycosides were concentration dependent at pH 7.4. At pH 6.5, the killing rates of amikacin and netilmicin were far lower than those observed at pH 7.4. At pH 5.5, amikacin and netilmicin exerted practically no bactericidal effect on the P. aeruginosa strain used. However, with media at pH 5.5 and 6.5, adaptive resistance of P. aeruginosa preexposed to amikacin and netilmicin was also clearly exhibited, with the degree of adaptive resistance depending on the bactericidal effects of both drugs on nonpreexposed controls. Maximal adaptive resistance occurred between 0 and 4 h after preexposure. The postantibiotic effects of amikacin and netilmicin against the P. aeruginosa strain were shown to be concentration dependent and were reduced at acidic pHs. No changes in outer and inner membrane proteins occurred during the adaptive-resistance interval.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8787875      PMCID: PMC163052     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation.

Authors:  G L Daikos; G G Jackson; V T Lolans; D M Livermore
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

Review 2.  Bacterial uptake of aminoglycoside antibiotics.

Authors:  H W Taber; J P Mueller; P F Miller; A S Arrow
Journal:  Microbiol Rev       Date:  1987-12

3.  Penicillin-binding protein 7 and its relationship to lysis of nongrowing Escherichia coli.

Authors:  E Tuomanen; J Schwartz
Journal:  J Bacteriol       Date:  1987-11       Impact factor: 3.490

4.  Tobramycin uptake in Escherichia coli is driven by either electrical potential or ATP.

Authors:  H S Fraimow; J B Greenman; I M Leviton; T J Dougherty; M H Miller
Journal:  J Bacteriol       Date:  1991-05       Impact factor: 3.490

5.  Outer membrane of Pseudomonas aeruginosa: heat- 2-mercaptoethanol-modifiable proteins.

Authors:  R E Hancock; A M Carey
Journal:  J Bacteriol       Date:  1979-12       Impact factor: 3.490

6.  Membrane potential and gentamicin uptake in Staphylococcus aureus.

Authors:  S M Mates; E S Eisenberg; L J Mandel; L Patel; H R Kaback; M H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

7.  Quantitative association between electrical potential across the cytoplasmic membrane and early gentamicin uptake and killing in Staphylococcus aureus.

Authors:  E S Eisenberg; L J Mandel; H R Kaback; M H Miller
Journal:  J Bacteriol       Date:  1984-03       Impact factor: 3.490

8.  Role of the membrane potential in bacterial resistance to aminoglycoside antibiotics.

Authors:  P D Damper; W Epstein
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

9.  Tobramycin uptake in Escherichia coli membrane vesicles.

Authors:  I M Leviton; H S Fraimow; N Carrasco; T J Dougherty; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

10.  Adaptive resistance following single doses of gentamicin in a dynamic in vitro model.

Authors:  M L Barclay; E J Begg; S T Chambers
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

View more
  12 in total

Review 1.  Aminoglycosides: activity and resistance.

Authors:  M P Mingeot-Leclercq; Y Glupczynski; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

2.  Hydrophobicity and outer membrane proteins of Shigella dysenteriae type 1 after treatment with subinhibitory concentrations of aminoglycosides.

Authors:  A Hostacká; E Karelová
Journal:  Folia Microbiol (Praha)       Date:  1997       Impact factor: 2.099

3.  Reverse engineering antibiotic sensitivity in a multidrug-resistant Pseudomonas aeruginosa isolate.

Authors:  Julie M Struble; Ryan T Gill
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

4.  Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices.

Authors:  Michael R Yeaman; Kimberly D Gank; Arnold S Bayer; Eric P Brass
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

5.  Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model.

Authors:  Y Q Xiong; J Caillon; M F Kergueris; H Drugeon; D Baron; G Potel; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

6.  Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.

Authors:  Ofir Menashe; Elena Kaganskaya; Timor Baasov; Sima Yaron
Journal:  Antimicrob Agents Chemother       Date:  2008-01-02       Impact factor: 5.191

7.  MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides.

Authors:  Didier Hocquet; Christelle Vogne; Farid El Garch; Anne Vejux; Naomasa Gotoh; Angela Lee; Olga Lomovskaya; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

Review 8.  Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence.

Authors:  M Fata Moradali; Shirin Ghods; Bernd H A Rehm
Journal:  Front Cell Infect Microbiol       Date:  2017-02-15       Impact factor: 5.293

9.  Expression of the MexXY Aminoglycoside Efflux Pump and Presence of an Aminoglycoside-Modifying Enzyme in Clinical Pseudomonas aeruginosa Isolates Are Highly Correlated.

Authors:  Alexander Seupt; Monika Schniederjans; Jürgen Tomasch; Susanne Häussler
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

10.  Parallel Evolution of High-Level Aminoglycoside Resistance in Escherichia coli Under Low and High Mutation Supply Rates.

Authors:  Claudia Ibacache-Quiroga; Juan C Oliveros; Alejandro Couce; Jesus Blázquez
Journal:  Front Microbiol       Date:  2018-03-19       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.